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Background: The COVID-19 global pandemic has resulted in a plethora of guidance and opinion from
surgical societies. A controversial area concerns the safety of surgically created smoke and the perceived
potential higher risk in laparoscopic surgery.
Methods: The limited published evidence was analysed in combination with expert opinion. A review was
undertaken of the novel coronavirus with regards to its hazards within surgical smoke and the procedures
that could mitigate the potential risks to healthcare staff.
Results: Using existing knowledge of surgical smoke, a theoretical risk of virus transmission exists.
Best practice should consider the operating room set-up, patient movement and operating theatre
equipment when producing a COVID-19 operating protocol. The choice of energy device can affect the
smoke produced, and surgeons should manage the pneumoperitoneummeticulously during laparoscopic
surgery. Devices to remove surgical smoke, including extractors, filters and non-filter devices, are
discussed in detail.
Conclusion: There is not enough evidence to quantify the risks of COVID-19 transmission in surgical
smoke. However, steps can be undertaken to manage the potential hazards. The advantages of minimally
invasive surgery may not need to be sacrificed in the current crisis.
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Introduction
The 2020 pandemic of the novel coronavirus, COVID-19,
has raised concerns about the risk of virus transmission
to staff in the operating room. This relates not just to
intubation and extubation of the airway during anaesthesia,
but also to the release of potential infectious particles in
laparoscopic smoke or plume.
The risks of laparoscopic smoke, or plume, have been
recognized for a long time, but the advent of COVID-19
has brought its importance into sharp relief1. The Society
of American Gastroenterology and Endoscopic Surgeons
updated their advice on 30 March 20202: ‘Although pre-
vious research has shown that laparoscopy can lead to
aerosolization of blood-borne viruses, there is no evi-
dence to indicate that this effect is seen with COVID-19,
nor that it would be isolated to MIS [minimally invasive
surgery] procedures. Nevertheless, erring on the side of
safety would warrant treating the coronavirus as exhibiting
similar aerosolization properties. For MIS procedures, use
of devices to filter released CO2 for aerosolized particles
should be strongly considered’.
A rapid, joint publication from Italian and Chinese
surgeons3 has shared excellent advice based on their expe-
riences in the preceding months. The UK and Ireland
Intercollegiate Board has also continued to update its
guidance. It moved from a statement that ‘laparoscopy
should generally not be used’ to its most recent guide-
line on 27 March 20204, which states: ‘Laparoscopy is
considered to carry some risks of aerosol-type formation
and infection and considerable caution is advised. The
level of risk has not been clearly defined and it is likely
that the level of PPE [personal protective equipment]
deployed may be important. Advocated safety mechanisms
(filters, traps, careful deflating) are difficult to implement.
Consider laparoscopy only in selected individual cases
where clinical benefit to the patient substantially exceeds
the risk of potential viral transmission in that particular
situation’. This expeditious advice is a pragmatic response
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to the widespread anxiety surrounding possible virus
transmission in the operating room.
This article reviews the best available evidence to under-
stand the risk of transmission of COVID-19 in laparoscopic
smoke, and what steps, based on physical properties of
the virus, may be best placed to reduce this and jus-
tify continuing laparoscopic surgery under strict safety
guidelines.
Risk of virus transmission in surgical smoke
There is currently no evidence that COVID-19 is trans-
missible through surgical smoke. Previous studies have,
however, demonstrated the presence of different viruses in
surgical smoke, including: corynebacterium, human papil-
lomavirus (HPV), poliovirus, human immunodeficiency
virus (HIV) and hepatitis B5–8. The aerosol produced by
laparoscopic or robotic surgery, particularly when using
low-temperature ultrasonic devices, may not effectively
deactivate the cellular components of a virus3.
The possibility of disease transmission through surgi-
cal smoke does exist in humans, but documented cases are
rare9. HPV transmission during anogenital surgery is the
most widely reported in the literature. This is most likely
due to the direct contact of electrocautery on an infected
field. Liu and colleagues9 outlined four articles10–13 link-
ing surgical smoke to the transmission of HPV (types 6, 11
and 13), progressing to oropharyngeal squamous cell carci-
noma.These cases occurred in otherwise fit healthcare pro-
fessionals performing gynaecological surgery with no other
risk factors for the disease. Another study14 found that one
in five surgeons, and three in five nurses, tested positive for
HPV after performing operations for laryngeal and ure-
thral papillomas14. The HPV genotypes in the infected
healthcare professional were identical to those identified in
the patient.
In addition to HPV transmission, Baggish and
co-workers reported that HIV proviral DNA was cap-
tured in the inner lumen of smoke evacuation tubing after
in vitro laser vaporization of cultured HIV cells15. Kwak
et al.16 further revealed that hepatitis B virus (HBV) was
present in surgical smoke16. In this study, surgical smoke
was collected during laparoscopic or robotic surgery in
11 patients. HBV was detected in ten of the 11 sam-
ples of surgical smoke, including that from non-hepatic
surgery. This suggests that bloodborne viruses may be
present within surgical smoke. Although the transmis-
sion of COVID-19 is, at present, felt to occur primarily
through respiratory droplets, there remains a theoret-
ical risk of virus aerosolization during minimal access
surgery17,18.
Physical properties of the coronavirus
It is essential to understand the physical properties of the
virus in order to predict the risk of transmission and the
effectiveness of preventative measures. The correct term
for the virus causingCOVID-19 is Sarbecovirus severe acute
respiratory syndrome coronavirus 2 (SARS-CoV2), which
is a member of the betacoronavirus family (subgenus Sar-
becovirus). Like its close relatives, Middle East respiratory
syndrome coronavirus (MERS-CoV) and SARS-CoV, it is
believed to have its origins in bats. Sequence analysis from
cases around the world strongly indicate that the pandemic
resulted from a single recent emergence of the virus from
an animal reservoir.
SARS-CoV2 is a positive-sense single-stranded RNA
virus, containing a linear genome of approximately 30 kb.
Like other members of the coronavirus family, the virion
is typically around 120 nm in diameter, although this can
vary from 50 to 200 nm19. As an enveloped virus, the RNA
genome is contained within a lipid bilayer containing sev-
eral proteins: the N protein binds and stabilizes the RNA
genome, and the envelope (E), membrane (M) and spike
(S) proteins make up the envelope. Like other members of
the SARS family, the virus uses the heavily glycosylated,
extended spike protein to mediate initial cellular engage-
ment and begin the process of infection20. The S protein of
SARS-CoV2 engages the angiotensin-converting enzyme
2 receptor (ACE2) as a high-affinity primary attachment
receptor21. ACE2 expression is abundant on human air-
way epithelial cells, consistent with efficient transmission
occurring via respiratory droplets. Other co-receptors may
also be involved in cellular infection, including CD147
(basigin, BSG) and CD2620,22. In each case, the interac-
tion is thought to occur with the S protein, which appears
pivotal for cellular tropism.
The extended S protein is a trimeric protein, each
monomer being approximately 1100 amino acids in length.
The structure of the protein (based on Protein Data Bank
(PDB) 6CRV) is depicted in Fig. 1a,b. Binding of ACE2
to S protein occurs at the apical domain. Although the
overall net virion charge has not yet been evaluated, it is
possible to assess the surface electric potential of individ-
ual capsid proteins where structures have been elucidated,
as depicted for the S protein in Fig. 1c,d. Fig. 1d shows
the full surface electric potential of the spike protein, as
viewed towards the virion. Areas of both positive and neg-
ative charge are visible in approximately equal abundance,
although the central depression, where ACE2 is thought
to bind, and one of the few regions of the S protein that is
devoid of glycosylation, is seen to be relatively negatively
charged.
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Fig. 1 Structure and isoelectric properties of SARS-CoV2 spike protein
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Structure of the SARS-CoV2 spike protein as viewed from top down (a) and in cross-section (b), based on Protein Data Bank (PDB) entry 6CRV. The
trimeric assembly, as viewed from top down, is shown as an amalgam cartoon (top), solid surface (right, yellow) and electric potential (left) (c), and the full
trimer overlaid with the full surface electric potential (d), highlighting a trefoil of negative charge (red) around the central point.
Operating theatre set-up
Excellent theatre discipline and the use of checklists is
highly recommended to minimize the risk of surgery and
anaesthesia, regardless of surgical approach. Expert recom-
mendations from China suggest using a designated operat-
ing theatre for COVID-19-positive patients23. This allows
patient movements to be planned, limiting the contamina-
tion of other clinical areas. The flow of theatre staff can
also be mapped to create designated areas for donning and
doffing full personal protective equipment. The minimum
number of staff should be present in the operating theatre,
with the minimum amount of equipment. A runner can
acquire further stock as required, but should be mindful to
minimize the number of entries into the operating theatre.
In deciding which operating theatre to use, the theatre
ventilation system should be considered. Negative pressure
ventilation can limit the contamination of surgical smoke
into neighbouring areas through doors and vents. During
the SARS outbreak in Hong Kong in 2004, Chow and
colleagues24 described how they converted existing sys-
tems into negative pressure systems. This may not always
be feasible, and so the recommendations from the UK
and Ireland surgical colleges are that positive pressure
ventilation should be halted during the procedure and for
at least 20min after the patient has left theatre4. The risks
of positive pressure ventilation, however, have not been
quantified. If the virus is present in laparoscopic smoke,
it must make its way to the edge of the theatre and then
must have an uplift in theatre corridors at a concentration
sufficient to be infective. Any virus load is likely to be
diluted massively by the time this happens.
Unidirectional air flow (laminar flow) systems remain
controversial in their ability to decrease surgical-site infec-
tions and so are not recommended by theWHO25,26. They
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produce a continuous flow of highly filtered ultraclean air
and can display 99⋅97 per cent efficiency in removing air-
borne particles of 0⋅3 μm and larger27. This would imply an
effectiveness in clearing COVID-19, but it is also necessary
to consider having multiple theatres available as sufficient
downtime between procedures is essential to ensure full
decontamination. If smoke is a risk factor, in a laminar flow
theatre it will be pushed to the floor, away from staff, and
the inhalation risk diminished.
There is a limited amount of evidence related to the
choice of tissue-cutting energy device used. Monopolar
electrocautery using Teflon® (Chemours, Delaware, USA)
blades and a feedback mechanism to automatically reduce
the voltage produces less surgical smoke28. The main
laparoscopic alternatives to electrocautery are the ultra-
sonic energy devices such as Harmonic Scalpel (ACE®;
Ethicon Endo-Surgery, Cincinnati, Ohio, USA). Although
such devices can add efficacy and speed to some laparo-
scopic procedures, more viable cells have been detected in
the smoke from ultrasonic energy devices29.
Mechanical measures for smoke evacuation
The operating room ventilation system is not the only
method of smoke extraction; protection from surgical
smoke can also be achieved by local extraction at the site
of surgery or by the use of personal filtration masks. There
are several benefits to using smoke extractors; they keep
the surgical field clear, prevent corrosion of equipment due
to released chemical, and reduce odour. However, for the
purpose of this review, the main benefit is that they cap-
ture the smoke close to the source of emission, therefore
minimizing exposure of healthcare professionals to poten-
tial contaminants andmaintaining a safer environment. For
this reason, the surgical colleges in the UK currently rec-
ommend their use4.
The particulate removal capability of smoke evacuator
devices is, by design, limited to the efficiency and size of
their filters. Other factors to consider include: the min-
imum flow rate (at least 0⋅012m3/s), the ability to vary
both the flow rate and noise level (ideally below 60 dB),
ergonomic features, portability, cost-effectiveness and ease
of maintenance30.
There are a number of types of filter available. Char-
coal filters use activated charcoal; they can absorb both
gas and vapour, and can eliminate strong-smelling gases.
Coconut shell charcoal is better at absorbing particulate
matter than wood-based charcoal owing to its greater inter-
nal pore area31. High-efficiency particulate air filters act
to filter suspended compounds. They can retain particles
larger than 0⋅3 μm at an efficiency rate of 99⋅97 per cent32.
Ultralow particulate air (ULPA) filters retain 99⋅9 per cent
of particles at 0⋅1 μm and are a depth filter, filtering mat-
ter by different methods depending on the particle size32.
This makes them ideal for removing the particles created
in electrosurgical and laser procedures.
The Association of periOperative Registered Nurses
guidelines33 state that perioperative personnel should use
ULPA filters routinely for surgical smoke. Currently the
most effective smoke evacuation system is the triple-filter
system, which includes a prefilter that captures large parti-
cles, a ULPA filter, and a special charcoal that captures the
toxic chemicals found in smoke. Triple-filter systems often
have variable suction volume capacity to accommodate var-
ious levels of smoke production.
Most commonly these filters are used in portable evacua-
tion machines, but in some instances a filter can be used in
the wall suction system to safely capture small amounts of
smoke. Depending on the environment, these filters may
require replacement after each use or each day. Most of
the evacuation devices have an inbuilt alarm or an indica-
tor light to signal a required change. A change of filter is
mandated when the suction pressure decreases or there is a
lingering odour in the air. The contaminated filter may be
considered as infectious or regulated waste depending on
the waste disposal protocol of the facility34. Table 1 sum-
marizes the currently available smoke evacuation devices.
Choi and colleagues36 assessed surgical smoke from 20
patients undergoing transperitoneal laparoscopic nephrec-
tomy for renal cell carcinoma. Surgical smoke (prefilter)
was collected 20min after the electrocautery device was
first used during the procedure and 2 h after the fil-
ter had been applied. The sample was analysed by gas
chromatography–mass spectroscopy. Strong carcinogens
were eliminated by more than 85 per cent by using the acti-
vated carbon fibre filter. Seipp and co-workers37 tested the
efficiency of portable smoke evacuation systems and found
that filtration reduced surgical smoke by up to 99 per cent.
However, this was accompanied by high noise levels that
exceeded recommended limits.
Despite recommendations from various professional
organizations advocating the use of smoke extraction
devices in operating rooms, these measures are not
being used widely because of excessive noise, high cost,
equipment maintenance issues, large bulky devices, and
resistance or complacency from clinical staff 38–40.
Laparoscopic trocars and release
of pneumoperitoneum
All minimally invasive surgeons will be aware that the
trocar represents a point of weakness, by penetrating the
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Table 1 Summary of commercially available smoke evacuation systems
CONMED
Cooper
Surgical® Ethicon Medtronic Olympus Stryker Northgate
Product name AirSeal®
(laparoscopic)
PlumePen®
(open)
Buffalo Filter®
Smoke
Management
SeeClear
Plume-away
Megadyne™
MegaVac
PLUS™
MegaVac™
MiniVac™
ValleyLab
RapidVac™
UHI-4 Pneumoclear™
PureView™
Neptune™ (open)
SafeAir™ (open)
Photonblade™
(open)
Smoke Evac
Retractors™
(open)
Nebulae™ I
system
Open Yes No Yes Yes No Yes No
Laparoscopic Yes Yes MegaVac
PLUS™ only
Yes Yes Yes Yes
ULPA Yes Yes Yes Yes No Yes Yes
Micron filtration 0⋅012 0⋅1 0⋅1 0⋅1–0⋅2 n.a. 0⋅051–0⋅1 0⋅12
Passive or active evacuation Active Passive Active Active Active Active Active
Reproduced from a document published by the Society of Gastrointestinal and Endoscopic Surgeons in conjunction with their guidelines for surgeons
concerning the use of laparoscopy during the current COVID-19 pandemic2,35. ULPA, ultralow particulate air; n.a., not available. CONMED, Utica, New
York, USA; CooperSurgical®, Trumbull, Connecticut, USA; Ethicon, Somerville, New Jersey, USA; Medtronic, Dublin, Ireland; Olympus, Shinjuku City,
Tokyo, Japan; Stryker, Kalamazoo, Michigan, USA; Northgate, Elgin, Illinois, USA.
abdominal wall and allowing the inadvertent escape of
pressurized carbon dioxide from the pneumoperitoneum.
This is an obvious area of concern in a COVID-19-positive
patient, and remains a risk throughout the procedure as
displacement of the port is not uncommon.
Pressurized intraperitoneal aerosol chemotherapy
(PIPAC) delivers aerosol chemotherapy under pres-
sure during laparoscopy for the treatment of peritoneal
carcinomatosis. By its very nature, the procedure has
necessitated a high level of investigation into ways of
mitigating the risk of gas leakage during surgery. Both
experimental and human models have shown that, with
the development of standard operating procedures (SOPs)
for laparoscopy, the risk of contamination of the operating
theatre environment with potentially harmful chemother-
apy agents is negligible41. The authors propose that these
procedures could be applied to minimally invasive surgery
on COVID-positive patients, similarly negating the risk of
virus escape during surgery.
Open Hasson umbilical port insertion may result in a
larger defect in the fascia than is required for the port,
allowing pressurized carbon dioxide to escape around the
trocar. PIPAC surgeons frequently use either off-midline
open cutdown or alternative first entry techniques (Veress,
optical insertion), which result in a fascia defect that is
more snug around the port, reducing the risk of gas leakage
at this site.
PIPAC SOPs recommend the use of balloon ports.
Balloon-secured trocars reduce the chance of inadvertent
displacement of the trocar during instrument changes,
thus reducing the risk of loss of pneumoperitoneum to
the operating theatre environment. Trocars also contain a
valve preventing gas leakage when an instrument is passed
through into the peritoneum; surgeons should be aware
of the inherent risks if the valve should become damaged.
In addition, the authors believe that, when the balloon
is inflated inside the peritoneum and traction is applied
against the posterior rectus sheath, a more secure seal is
achieved around the body of the trocar, therefore reducing
the risk of gas leakage.
Ten-millimetre ports should be closed under direct vision
once the pneumoperitoneum has been safely evacuated
using techniques described elsewhere in this article. The
authors recommend against the use of devices such as
EndoClose™ (Medtronic, Dublin, Ireland), which require
maintenance of the pneumoperitoneum to facilitate clo-
sure, as this will increase the risk of gas leakage.
Pneumoperitoneum should be maintained throughout
the procedure at the lowest possible pressure. At the end of
the procedure, the pneumoperitoneum should be removed
in a controlled fashion by first switching off the insufflation,
and then aspirating the pneumoperitoneum using a suction
device (preferably passed through a filter mechanism)42.
If specimen extraction is required, the pneumoperitoneum
should be decompressed safely as above before making an
incision for specimen extraction.
Non-filtration devices
The Ultravision™ system (Alesi Surgical, Cardiff, UK)
removes smoke and particulate matter produced during
electrosurgical procedures, as an aid to maintaining a clear
visual field. Active throughout surgery, the system prevents
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the build-up of smoke by electrostatically precipitating
particulate matter generated within the peritoneal cavity
during the use of electrosurgical tools. It has been shown
to negate the periprocedural venting of insufflation gas to
facilitate clearance of smoke43.
The principle on which the Ultravision™ system oper-
ates is derived from electrostatic precipitators that are
widely used to remove fine particulate matter from exhaust
gases produced during, for example, the commercial man-
ufacture of cement and paper. The system comprises a
generator and a single-use electrode that together create
negative ions in the abdominal cavity. These ions impart a
transient negative charge to the particles of surgical smoke
as they are created. The electrostatically charged particles
are attracted to the patient tissue owing to the presence of
the standard patient return electrode used during surgery.
The charge is neutralized as each particle precipitates on
to the surface of the peritoneal wall, where it remains
unchanged physically and chemically44,45. Ultravision™
has also been used to enhance safety in PIPAC46. The
functionality of the system is not restricted by particle size,
and it has been demonstrated to remove over 99 per cent
of all smoke particulates larger than 7 nm in size47.
Conclusion
There is not enough evidence available to allow a bal-
anced risk estimation for the infectious nature of surgical
smoke. It is unclear whether laparoscopic smoke repre-
sents a greater risk than that created during open surgery.
Given the novel status of the COVID-19 pathogen, and the
evidence of other viruses being present in surgical smoke,
maximizing intraoperative precautions at this time would
seem prudent. There has never been a time when knowl-
edge and guidelines are changing on an almost daily basis
as a result of the unprecedented worldwide communication
and information sharing. Minimal access surgery offers
advantages to patients in terms of hospital stay. With strict
locally agreed theatre protocols aligned to evidence-based
protective measures, it may be possible to continue to offer
minimal access surgery to those who might benefit most.
Disclosure
J.T. holds stock in Alesi Surgical and has received educa-
tional grants from Medtronic and Ethicon. The authors
declare no other conflict of interest.
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